Simon · European journal of psychotraumatology 2025 · qualitative interview study · n=45

Psychedelics and collective trauma: multisystemic resilience and recovery pathways among Nova festival survivors - a qualitative study.

Cited 6 times in the scientific literature.

Level 4 - case-series / case-control

Qualitative interview study (descriptive/phenomenological)

PubMed 41222082 · doi:10.1080/20008066.2025.2582303 · record verified 2026-08-28

What was done

Researchers conducted semi-structured interviews with 45 Israeli survivors (25 male, 20 female) of the October 7, 2023 Nova festival attack who were recruited through a trauma-support nonprofit organization. All participants reported being under the influence of at least one psychoactive substance during the attack and subsequently engaged in psychological support. Data were examined using Reflexive Thematic Analysis with a phenomenological orientation, supported by reflexivity journaling, peer debriefing, and researcher positionality statements.

What was found

The abstract reports qualitative themes rather than numerical data. Survivor narratives revealed two interrelated recovery pathways: (1) Interpersonal and Therapeutic Supports, encompassing formal psychotherapy, therapeutic alliances that validated altered states, and peer solidarity providing emotional safety; and (2) Collective Healing Practices, including grassroots initiatives, community retreats, rituals, and culturally meaningful commemorations that reframed traumatic experiences within supportive community contexts.

Why it matters

The study offers exploratory insight into how acute mass trauma experienced during altered states of consciousness is integrated during recovery. It underscores the value of multisystemic, community-driven care and nonjudgmental, psychedelic-informed trauma support.

Limits

The sample is qualitative, non-randomized, and restricted to 45 individuals who actively engaged with a trauma-support nonprofit, introducing self-selection bias. The abstract does not quantify specific psychoactive substances, doses, baseline trauma severity, or standardized clinical psychiatric outcomes.

Cited by